A recent decision analytical modelling study, using a "health-augmented macroeconomic model...to estimate the global economic cost of 29 cancer types for 204 countries..." is the first of its kind to study productivity loss among individuals with different educational and experience levels. Study authors have found the estimated global economic cost of cancers from 2020-2050 to be $25.2 trillion, with tracheal bronchus, and lung cancer (15.4%), colon and rectal cancer (10.9%), breast cancer (7.7%), liver cancer (6.5%), and leukaemia (6.3%) deemed to sustain the highest economic costs.
To read more about this study, click here.
Sources mentioned:
- Chen S, Cao Z, Prettner K, et al. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncology; Published online 23 February 2023. doi:10.1001/jamaoncol.2022.7826
- Lopes G. The Global Economic Cost of Cancer—Estimating It Is Just the First Step! JAMA Oncology; Published online 23 February 2023. doi:10.1001/jamaoncol.2022.7133
No comments:
Post a Comment